Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent
1979-02-05
1981-06-23
Waltz, Thomas A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
26050117, 424211, 424230, 424317, 424330, 564349, 564351, N61K 31135, C07C 8728
Patent
active
042750580
ABSTRACT:
1-Indanyloxy- or tetrahydronaphthyloxy-3-amino-2-butanol derivatives, especially erythro-1-(7-methylindan-4-yloxy)-3-isopropylaminobutan-2-ol, processes for their manufacture and pharmaceutical compositions containing them. The compounds possess peripherally-selective .beta.-adrenergic blocking activity.
REFERENCES:
patent: 3337628 (1967-08-01), Crowther et al.
patent: 3415873 (1968-12-01), Stevens
patent: 3501769 (1970-03-01), Crowther et al.
patent: 3534085 (1970-10-01), Narayanan et al.
patent: 3646066 (1972-02-01), Narayanan et al.
patent: 4029676 (1977-06-01), Hauck et al.
patent: 4048231 (1977-09-01), Hauck et al.
patent: 4127675 (1978-11-01), Murakami et al.
British J. Pharm., 1970, 39, 139, Levy et al.
British J. Pharm., 1973, 49, 514, Levy.
Fitzgerald et al., Federation Proceedings, 1975, 721.
Manufacturing Chemist, 37, p. 56 (1966).
Imperial Chemical Industries Limited
Waltz Thomas A.
LandOfFree
.beta.-Adrenergic blocking alkanolamine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .beta.-Adrenergic blocking alkanolamine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .beta.-Adrenergic blocking alkanolamine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2207642